Browsing Tag
Dr. Nazli Azimi
1 post
Bioniz Therapeutics reports positive phase 1/2 trial data for BNZ-1 in treating relapsed/refractory CTCL
Bioniz Therapeutics, a leading player in the field of peptide-based therapeutics, has revealed promising data from a phase…